Compile Data Set for Download or QSAR
Report error Found 604 Enz. Inhib. hit(s) with all data for entry = 2834
TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382044(2-[1-[(3- fluorophenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382044(2-[1-[(3- fluorophenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382043(2-[1-(1-phenylethyl)imidazol-4- yl]pyridine-4-carb...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382045(2-[1-[2-(2-chlorophenyl)-2- methylpropyl]imidazol-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382045(2-[1-[2-(2-chlorophenyl)-2- methylpropyl]imidazol-...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382044(2-[1-[(3- fluorophenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382042(2-[1-[(2- fluorophenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382042(2-[1-[(2- fluorophenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 4A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382043(2-[1-(1-phenylethyl)imidazol-4- yl]pyridine-4-carb...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of JMJD2A was determined in 384-well plate format under the following reaction conditions: 2 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 4C(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382043(2-[1-(1-phenylethyl)imidazol-4- yl]pyridine-4-carb...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of JMJD2C was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382043(2-[1-(1-phenylethyl)imidazol-4- yl]pyridine-4-carb...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382043(2-[1-(1-phenylethyl)imidazol-4- yl]pyridine-4-carb...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382048(2-[1-(2-methyl-1- phenylpropyl)imidazol-4- yl]pyri...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382047(2-[1-(1-phenylpropyl)imidazol-4- yl]pyridine-4-car...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 4A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382047(2-[1-(1-phenylpropyl)imidazol-4- yl]pyridine-4-car...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of JMJD2A was determined in 384-well plate format under the following reaction conditions: 2 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382048(2-[1-(2-methyl-1- phenylpropyl)imidazol-4- yl]pyri...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382048(2-[1-(2-methyl-1- phenylpropyl)imidazol-4- yl]pyri...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382046(2-[1-(1-phenylpropan-2- yl)imidazol-4-yl]pyridine-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382046(2-[1-(1-phenylpropan-2- yl)imidazol-4-yl]pyridine-...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382045(2-[1-[2-(2-chlorophenyl)-2- methylpropyl]imidazol-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382047(2-[1-(1-phenylpropyl)imidazol-4- yl]pyridine-4-car...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382047(2-[1-(1-phenylpropyl)imidazol-4- yl]pyridine-4-car...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382046(2-[1-(1-phenylpropan-2- yl)imidazol-4-yl]pyridine-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382051(2-[1-[(3- phenylphenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382051(2-[1-[(3- phenylphenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382050(2-[1-(4-fluoro-2,3-dihydro-1H- inden-1-yl)imidazol...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382052(2-[1-(2-naphthalen-1- ylethyl)imidazol-4-yl]pyridi...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382051(2-[1-[(3- phenylphenyl)methyl]imidazol-4- yl]pyrid...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382049(2-[1-(6-fluoro-2,3-dihydro-1H- inden-1-yl)imidazol...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382049(2-[1-(6-fluoro-2,3-dihydro-1H- inden-1-yl)imidazol...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382050(2-[1-(4-fluoro-2,3-dihydro-1H- inden-1-yl)imidazol...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382050(2-[1-(4-fluoro-2,3-dihydro-1H- inden-1-yl)imidazol...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382049(2-[1-(6-fluoro-2,3-dihydro-1H- inden-1-yl)imidazol...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382054(2-[1-(2-cyclohexylethyl)imidazol- 4-yl]pyridine-4-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382054(2-[1-(2-cyclohexylethyl)imidazol- 4-yl]pyridine-4-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382054(2-[1-(2-cyclohexylethyl)imidazol- 4-yl]pyridine-4-...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382055(2-[1-(cyclohexylmethyl)imidazol- 4-yl]pyridine-4-c...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382055(2-[1-(cyclohexylmethyl)imidazol- 4-yl]pyridine-4-c...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382055(2-[1-(cyclohexylmethyl)imidazol- 4-yl]pyridine-4-c...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382052(2-[1-(2-naphthalen-1- ylethyl)imidazol-4-yl]pyridi...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382052(2-[1-(2-naphthalen-1- ylethyl)imidazol-4-yl]pyridi...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382053(2-[1-[2-(3- chlorophenyl)ethyl]imidazol-4- yl]pyri...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382053(2-[1-[2-(3- chlorophenyl)ethyl]imidazol-4- yl]pyri...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382053(2-[1-[2-(3- chlorophenyl)ethyl]imidazol-4- yl]pyri...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of Jarid1A activity is based upon Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The ability of test c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382058(2-[5-[2-(cyclopropylmethoxy)-4- fluorophenyl]-1-me...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382058(2-[5-[2-(cyclopropylmethoxy)-4- fluorophenyl]-1-me...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382060(2-[5-[2-(cyclopropylmethoxy)-6- fluorophenyl]-1-me...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 2B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382059(2-[5-[2-(cyclopropylmethoxy)- 4,5-difluorophenyl]-...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of FBXL10 was determined in 384-well plate format under the following reaction conditions: 0.3 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 4A(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382056(2-[1-(1,2,3,4- tetrahydronaphthalen-1- ylmethyl)im...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of JMJD2A was determined in 384-well plate format under the following reaction conditions: 2 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

TargetLysine-specific demethylase 5B(Human)
Celgene Quantscel Research

US Patent
LigandPNGBDBM382056(2-[1-(1,2,3,4- tetrahydronaphthalen-1- ylmethyl)im...)
Affinity DataIC50: 100nMAssay Description:The ability of test compounds to inhibit the activity of Jarid1B was determined in 384-well plate format under the following reaction conditions: 0.8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
US Patent

Displayed 1 to 50 (of 604 total ) | Next | Last >>
Jump to: